E5 Lacount mcmp Flashcards

1
Q

is mycobacterium TB GN or GP

A

neither its acid fast

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Mycobacterium TB can be _______ and form ________

A

dormant
granulomas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what does acid fast mean?

A

these bacteria retain a dye stain even after a strong acid wash

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

acid fast bacteria retain a dye stain, why is this?

A

lipid-rich cell wall that contains mycolic acids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what is significantly different in mycobacteria cell walls vs GP and GN?

A

more complex and lipid-heavy than either of those, also resistant to a ton of antibiotics due to impermeability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

most common tx of active TB infection (4)

A

combo of rifampin, isoniazid, pyrazinamide, and ethambutol (RIPE)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

alternative tx of active TB infection

A

rifapentine, isoniazid, pyrazinamide, moxi

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

why do we use a combo of drugs when treating active TB

A

different drugs are needed to combat dividing and dormant forms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

isoniazid activation

A

prodrug activated by KatG (a catalase-peroxidase in M. tb)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

isoniazid MOA:

A
  • forms NAD+ and NADP+ adducts that inhibit InhA and KasA (enzymes involved in mycolic acid synthesis
  • inhibits FAS-II system -> halts cell wall formation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

isoniazid resistance mechs (2)

A
  • mutation or overexpression of InhA
  • mutations that affect KatG activation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

contribution Isoniazid makes to an effective anti-
tuberculosis treatment (cidal/static + other shit)

A
  • cidal
  • active against actively dividing mycobacterium TB
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

activation of rifampin

A

not a prodrug, not activated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

MOA of rifampin (2)

A
  • binds to rna polymerase in DNA/RNA channel
  • blocks the path of elongating RNA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

contribution rifampin makes to an effective anti-
tuberculosis treatment (cidal/static + other shit) (5)

A
  • cidal
  • most effective 1st line agent
  • works on growing AND stationary cells
  • high sterilizing activity
  • shortens duration of therapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

when is rifampin most effective?

A

when cell division is occuring

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

ethambutol activation

A

not a prodrug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

ethambutol MOA

A

inhibits mycobacterial arabinosyl transferases -> blocking arabinogalactan and LAM synthesis in cell wall

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

ethambutol resistance

A

overexpression/mutations in arabinosyl transferase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

niche AE of rifampin

A

colors urine, tears, and sweat orange

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

what is ethambutol synergistic with and why?

A

rifampin -> increase penetration into cell

22
Q

one important toxicity of ethambutol

A

optic neuritis

23
Q

ethambutol cidal or static

24
Q

activation of pyrazinamide

A

prodrug activated to pyrazinoic acid by pncA (nicotinamidase)
requires acidic pH <5.5 for activity

25
Pyrazinamide mechanism (best evidence)
- inhibition of panD leading to inhibition of Coenzyme A synthesis (this is very confusing so hopefully there's not a question about it)
26
eh pyrazinamide mechanism continued: - panD binding affinity is (low/high) - POA (does/does not) inhibit panD efficiently - Binding leads to _______ of panD - Accumulation in ______ offsets low binding affinity
-low - does not - degradation - granuloma
27
pyrazinamide resistance: primarily (1) can also be (3)
- primarily due to mutations in pncA - can also be panD, RpsA, ClpC1
28
most common side effect pyrazinamide then most dangerous
joint pain (arthralgia) hepatitis
29
contribution of pyrazinamide to TB tx (2)
- sterilizing agent against intracellular M. TB - shortens treatment to 6 months
30
what is the main FQ we will use in tx of TB
moxi
31
mechanism of moxi (3)
- traps gyrase on DNA ternary complex - prevents resolution of supercoiled DNA - disrupts DNA replication
32
moxi cidal or static
cidal
33
contribution of moxi in tx of TB (2)
- can replace ethambutol in certain regimens - superior tissue penetration and lesion killing than the other FQs
34
does not cause hepatitis: A. isoniazid B. moxifloxacin C. pyrazinamide D. rifampin
B
35
which of the following causes eye damage? A. isoniazid B. moxifloxacin C. Ethambutol D. rifampin
C
36
what are the 3 drugs in the BPaL regimen?
bedaquiline pretomanid linezolid
37
when is BPaL considered?
extensively drug-resistant TB or treatment-intolerant or non-responsive multidrug-resistant TB
38
activation of bedaquiline
not a prodrug dont worry
39
how is bedaquiline adminstered
oral
40
bedaquiline cidal or static
cidal
41
T or F: bedaquiline kills actively growing and dormant bacilli
true
42
MOA of bedaquiline
inhibits ATP synthase -> disrupts energy production in active and dormant bacilli
43
resistance of bedaquiline
mutations in atpE
44
what class is pretomanid in
nitroimidazoles
45
activation of pretomanid
activated by M. tb deazaflavin-dependent nitroreductase
46
MOA of pretomanid: aerobic: anaerobic/dormant:
- forms a reactive intermediate that inhibits mycolic acid synthesis - generates reactive nitrogen species -> poisons respiratory complex + depletes ATP
47
Pretomanid contributions to tx of TB (2)
-kills both replicating and persistent bacilli - enhances immune-mediated killing
48
second line agents fall under what general category for tx of TB?
anti-tubercular agents*
49
4 times second line agents are usually considered
- resistance to first line agent - failure of clinical response to first line agents - intolerance to first line agents - expert guidance available to deal with toxic side effects
50
what are the 5 second line agents used in tx of TB
- streptomycin - ethionamide - para-aminosalicylic acid - cycloserine - capreomycin